Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

ImmunityBio (IBRX) Receivables - Other (2016 - 2025)

ImmunityBio (IBRX) has disclosed Receivables - Other for 11 consecutive years, with $46000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 77.0% to $46000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46000.0 through Dec 2025, down 77.0% year-over-year, with the annual reading at $46000.0 for FY2025, 77.0% down from the prior year.
  • Receivables - Other for Q4 2025 was $46000.0 at ImmunityBio, up from $18000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $3.9 million in Q1 2022, with the low at $18000.0 in Q3 2025.
  • Average Receivables - Other over 5 years is $1.3 million, with a median of $1.3 million recorded in 2021.
  • The sharpest move saw Receivables - Other surged 387.8% in 2021, then crashed 97.53% in 2025.
  • Over 5 years, Receivables - Other stood at $1.3 million in 2021, then surged by 41.79% to $1.9 million in 2022, then increased by 6.83% to $2.0 million in 2023, then plummeted by 90.09% to $200000.0 in 2024, then crashed by 77.0% to $46000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $46000.0, $18000.0, and $67000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.